Archive Coverage of Tisch MSRCNY publications and interviews. 2024(1)2023(4)2022(2) Explore the Archive FDA-Approved Phase II Stem Cell Treatment Trial Shows Significant and Diverse Improvements for Multiple Sclerosis (MS) Patients Press url FDA-Approved Phase II Stem Cell Treatment Trial Shows Significant and Diverse I… 06.05.2024
FDA-Approved Phase II Stem Cell Treatment Trial Shows Significant and Diverse Improvements for Multiple Sclerosis (MS) Patients Press url FDA-Approved Phase II Stem Cell Treatment Trial Shows Significant and Diverse I… 06.05.2024
